PA
NEXT icon

PharVision Advisers’s NextDecade NEXT Stock Holding History

PharVision Advisers’s Portfolio NEXT Stock Details NEXT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$134K Buy
+17,550
New +$99.8K 1.36% 20

Other funds holding NEXT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
MIPU
Man Investment Partners (US) New York $84.3M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CCA
Catalyst Capital Advisors Huntington, New York $5.37B AUM 18.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
NIM
NEOS Investment Management Westport, Connecticut $19.8B AUM 31.12% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

PharVision Advisers's NEXT Position: Q1 2026 in Review

PharVision Advisers opened a new position in NextDecade (NEXT) in Q1 2026: 17,550 shares worth $134K. The stake represents 1.36% of the portfolio and ranks #20 among its holdings.

207 funds tracked by Wall St. Rank hold NEXT as of Q1 2026.

  • PharVision Advisers held 17,550 shares of NextDecade worth $134K as of Q1 2026.
  • NextDecade was a new PharVision Advisers position in Q1 2026.
  • NextDecade made up 1.36% of PharVision Advisers's portfolio in Q1 2026, its #20 holding.
  • 207 funds tracked by Wall St. Rank held NextDecade as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.